Goldman Sachs Group Inc Verona Pharma PLC Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Verona Pharma PLC stock. As of the latest transaction made, Goldman Sachs Group Inc holds 278,055 shares of VRNA stock, worth $17.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
278,055
Previous 32,889 745.43%
Holding current value
$17.4 Million
Previous $946,000 1264.9%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$28.71 - $47.02 $7.04 Million - $11.5 Million
245,166 Added 745.43%
278,055 $12.9 Million
Q3 2024

Nov 14, 2024
SELL
$15.46 - $30.16 $1.45 Million - $2.83 Million
-93,684 Reduced 74.02%
32,889 $946,000
Q2 2024

Aug 13, 2024
BUY
$11.48 - $17.02 $387,943 - $575,156
33,793 Added 36.42%
126,573 $1.83 Million
Q1 2024

May 15, 2024
BUY
$15.3 - $20.24 $806,508 - $1.07 Million
52,713 Added 131.56%
92,780 $1.49 Million
Q4 2023

Feb 13, 2024
BUY
$11.94 - $20.47 $175,135 - $300,253
14,668 Added 57.75%
40,067 $796,000
Q3 2023

May 14, 2024
SELL
$16.3 - $22.09 $239,088 - $324,016
-14,668 Reduced 36.61%
25,399 $414,000
Q3 2023

Nov 14, 2023
BUY
$16.3 - $22.09 $56,283 - $76,276
3,453 Added 15.73%
25,399 $414,000
Q2 2023

May 14, 2024
BUY
$19.41 - $23.43 $29,522 - $35,637
1,521 Added 7.45%
21,946 $463,000
Q2 2023

Aug 14, 2023
BUY
$19.41 - $23.43 $29,522 - $35,637
1,521 Added 7.45%
21,946 $463,000
Q1 2023

May 14, 2024
BUY
$18.06 - $25.27 $46,540 - $65,120
2,577 Added 14.44%
20,425 $410,000
Q1 2023

May 11, 2023
BUY
$18.06 - $25.27 $46,540 - $65,120
2,577 Added 14.44%
20,425 $410,000
Q4 2022

May 14, 2024
SELL
$9.84 - $26.13 $182,158 - $483,718
-18,512 Reduced 50.91%
17,848 $466,000
Q4 2022

Feb 13, 2023
SELL
$9.84 - $26.13 $182,158 - $483,718
-18,512 Reduced 50.91%
17,848 $466,000
Q3 2022

May 14, 2024
BUY
$4.14 - $13.59 $102,535 - $336,583
24,767 Added 213.64%
36,360 $372,000
Q3 2022

Nov 10, 2022
BUY
$4.14 - $13.59 $102,535 - $336,583
24,767 Added 213.64%
36,360 $371,000
Q2 2022

May 14, 2024
SELL
$3.55 - $5.06 $101,082 - $144,078
-28,474 Reduced 71.07%
11,593 $49,000
Q2 2022

Aug 15, 2022
BUY
$3.55 - $5.06 $41,155 - $58,660
11,593 New
11,593 $49,000

Others Institutions Holding VRNA

# of Institutions
218
Shares Held
67.5M
Call Options Held
1.4M
Put Options Held
299K
View Full List

About Verona Pharma plc

VRNA Quotes by TradingView
  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $3.82B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email